홈
마켓
차트 & 아이디어
Algo
뉴스
스토어
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
히트맵
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
B
BBP
Virtus LifeSci Biotech Products ETF
86.2
6
USD
-1.23%
부문:
금융
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
-1.23%
월간 변동
+2.41%
6달 변화
+9.58%
년간 변동율
+53.38%
이전 종가
87.3
3
Open
86.2
6
저가
86.2
6
High
86.2
6
양
1
마켓
US ETFs
BBP
전체 차트 열기
Full chart
개요
모든 보유 자산
히트맵
주요 보유 종목
Market Value
Shares
Weight %
TBPH
THERAVANCE BIOPHARMA INC
712.4 K
37.6 K
1.6%
VRTX
VERTEX PHARMACEUTICALS INC
710.0 K
1 511.0
1.6%
BIIB
BIOGEN INC
705.7 K
3 923.0
1.6%
BBIO
Bridgebio Pharma Inc
702.6 K
9 093.0
1.6%
Ascendis Pharma A/S
700.9 K
3 100.0
1.6%
IONS
IONIS PHARMACEUTICALS INC
698.9 K
8 454.0
1.6%
LGND
LIGAND PHARMACEUTICALS
692.5 K
3 605.0
1.5%
EXEL
EXELIXIS INC
691.4 K
16.7 K
1.5%
GERN
Geron Corp
688.4 K
502.5 K
1.5%
AGIO
AGIOS PHARMACEUTICALS INC
687.6 K
25.1 K
1.5%
REGN
REGENERON PHARMACEUTICALS
682.9 K
921.0
1.5%
PTCT
PTC Therapeutics Inc
682.3 K
9 033.0
1.5%
SNDX
Syndax Pharmaceuticals Inc
681.4 K
33.5 K
1.5%
CRNX
Crinetics Pharmaceuticals Inc
675.9 K
13.5 K
1.5%
ARWR
Arrowhead Pharmaceuticals Inc
675.9 K
9 749.0
1.5%
ROIV
Roivant Sciences Ltd
668.5 K
30.9 K
1.5%
UTHR
UNITED THERAPEUTICS CORP
648.8 K
1 382.0
1.4%
SRPT
SAREPTA THERAPEUTICS INC
645.6 K
31.7 K
1.4%
PHAT
Phathom Pharmaceuticals Inc
641.6 K
46.9 K
1.4%
TGTX
TG Therapeutics Inc
641.5 K
21.8 K
1.4%
1
2
3
4
뉴스
First Quarter Earnings: Sharpening Sector Divergence
3 Reasons To Stick With Growth Stocks In Rotating Markets
Seeking Innovation Beyond Tech? Insight On Healthcare Stocks
Makary's Successor Faces Tough Task Managing FDA Amid Budget Cuts
What's The Dominant Trend In Earnings: AI Or Geopolitics?
Medical Technology Stocks: Innovation Endures As Valuations Reset
AI And The Future Of Healthcare
Global PMI: Tracking The Sectors Hit Hardest By The Middle East War
Can Forgotten Biotech Break Out?
Concerns Shift From Obsolescence To Oil
CDT Insider Sentiment March 2026: The Probability Race And Barbell Strategies
ImmunityBio Lead Bladder Cancer Drug Trial Clears Power Check - ImmunityBio (NASDAQ:IBRX)